-
SciSparc and Clearmind Medicine Inc. Collaboration Yields New Patent Application for Psychedelic Combination Treatment for Binge Behaviors
Preclinical study results demonstrated the combination of SciSparc’s CannAmide™ with Clearmind’s MEAI has the potential to reduce alcohol consumption TEL AVIV,…
Read More » -
Text messaging program linked to improved lifestyle risk factors for heart attack survivors
[ad_1] Research Highlights: A study in Australia using a customized text message program to support and remind heart attack survivors…
Read More » -
Tauriga Sciences Inc. Chief Executive Officer Completes 1,500,000 Share Insider Purchase
[ad_1] New York, NY – (NewMediaWire) – May 9, 2022 – Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”),…
Read More » -
Investment, action urged to improve access, quality and equity in women’s heart health
[ad_1] Advisory Highlights: Women continue to be underrepresented in research for cardiovascular disease (CVD), leading to gaps in knowledge and…
Read More »